Brief: OncoCyte Board Has Appointed Andrew Arno As Chairman Of Board

Insight Molecular Diagnostics

11/05/2022 23:00

May 11 (Reuters) - OncoCyte Corp  OCX.O :
    * ONCOCYTE - CAVAN REDMOND HAS STEPPED DOWN AS CHAIRMAN OF
BOARD,
AND BOARD HAS APPOINTED ANDREW ARNO AS CHAIRMAN OF BOARD
EFFECTIVE MAY 6, 2022
    * ONCOCYTE CORP - MITCHELL LEVINE, CO'S CFO SINCE 2017, WILL
NO
LONGER SERVE IN THAT CAPACITY AS OF JUNE 1, 2022
    * ONCOCYTE - ANISH JOHN, VICE PRESIDENT, OPERATIONS –
TRANSPLANT,
HAS BEEN APPOINTED SENIOR VICE PRESIDENT, FINANCE, INTERIM CFO
EFFECTIVE JUNE 1, 2022
    * ONCOCYTE - ON JUNE 1, LEVINE WILL TRANSITION TO NEW ROLE
AS
CORPORATE DEVELOPMENT OFFICER OF CO WITH FOCUS ON CORPORATE AND
BUSINESS DEVELOPMENT

Source text for Eikon: [https://bit.ly/3NdoMc9]
Further company coverage:  OCX.O 

 ((Reuters.Briefs@thomsonreuters.com;))